Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Therapeutic Effects of Different Animal Bile Powders on Lipid Metabolism Disorders and Their Composition Analysis.

Tytuł:
Therapeutic Effects of Different Animal Bile Powders on Lipid Metabolism Disorders and Their Composition Analysis.
Autorzy:
Chen DX; Academy of Integrative Medicine Cardiovascular Research Institute, Fuzhou, 350122, China.; Fujian Key Laboratory of Integrative Medicine on Geriatric, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China.; Chen Ke-ji Academic Thought Heritage Studio, Fuzhou, 350122, China.
Chu JF; Academy of Integrative Medicine Cardiovascular Research Institute, Fuzhou, 350122, China.; Fujian Key Laboratory of Integrative Medicine on Geriatric, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China.; Chen Ke-ji Academic Thought Heritage Studio, Fuzhou, 350122, China.
Lin S; Academy of Integrative Medicine Cardiovascular Research Institute, Fuzhou, 350122, China.; Fujian Key Laboratory of Integrative Medicine on Geriatric, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China.; Chen Ke-ji Academic Thought Heritage Studio, Fuzhou, 350122, China.
Zhang L; Academy of Integrative Medicine Cardiovascular Research Institute, Fuzhou, 350122, China.; Fujian Key Laboratory of Integrative Medicine on Geriatric, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China.
Chen HW; Academy of Integrative Medicine Cardiovascular Research Institute, Fuzhou, 350122, China.; Fujian Key Laboratory of Integrative Medicine on Geriatric, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China.; Chen Ke-ji Academic Thought Heritage Studio, Fuzhou, 350122, China.
Sun ZW; Academy of Integrative Medicine Cardiovascular Research Institute, Fuzhou, 350122, China.; Fujian Key Laboratory of Integrative Medicine on Geriatric, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China.
Xu JF; Fujian Guizhentang Pharmaceutical Co., Ltd., Huian, Fujian Province, 362142, China.
Cai QY; Academy of Integrative Medicine Cardiovascular Research Institute, Fuzhou, 350122, China.; Fujian Key Laboratory of Integrative Medicine on Geriatric, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China.; Chen Ke-ji Academic Thought Heritage Studio, Fuzhou, 350122, China.
Wang LL; Academy of Integrative Medicine Cardiovascular Research Institute, Fuzhou, 350122, China.; Fujian Key Laboratory of Integrative Medicine on Geriatric, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China.
Peng J; Academy of Integrative Medicine Cardiovascular Research Institute, Fuzhou, 350122, China. .; Fujian Key Laboratory of Integrative Medicine on Geriatric, Fujian University of Traditional Chinese Medicine, Fuzhou, 350122, China. .; Chen Ke-ji Academic Thought Heritage Studio, Fuzhou, 350122, China. .
Źródło:
Chinese journal of integrative medicine [Chin J Integr Med] 2022 Oct; Vol. 28 (10), pp. 918-923. Date of Electronic Publication: 2021 Feb 20.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Publication: 2007- : Berlin : Chinese Journal of Integrated Traditional and Western Medicine Press : Springer
Original Publication: Beijing, China : Watertown, MA : Chinese Association of the Integration of Traditional and Western Medicine : China Academy of Traditional Chinese Medicine ; Distributed by Relaxing Natural Health, [2003]-
MeSH Terms:
Lipid Metabolism Disorders*/metabolism
Ursidae*/metabolism
Animals ; Bile/chemistry ; Bile/metabolism ; Biomarkers/metabolism ; Body Weight ; Cattle ; Diet, High-Fat ; Female ; Lipid Metabolism ; Lipids/analysis ; Liver/metabolism ; Powders ; Rats ; Rats, Sprague-Dawley ; Swine ; Taurodeoxycholic Acid/analysis ; Taurodeoxycholic Acid/metabolism ; Ursodeoxycholic Acid/analysis ; Ursodeoxycholic Acid/metabolism
References:
Wang XH, Li CY, Muhammad I, Zhang XY. Fatty acid composition in serum correlates with that in the liver and non-alcoholic fatty liver disease activity scores in mice fed a high-fat diet. Environ Toxi Pharm 2016;44:140–150. (PMID: 10.1016/j.etap.2016.04.009)
Lee HS, Lee YJ, Chung YH, Nam Y, Kim ST, Park ES, et al. Beneficial effects of red yeast rice on high-fat diet-induced obesity, hyperlipidemia, and fatty liver in mice. J Med Food 2015;18:1095–1102. (PMID: 10.1089/jmf.2014.3259)
Tacer KF, Rozman D. Nonalcoholic fatty liver disease: focus on lipoprotein and lipid deregulation. J Lipids 2011;783976:1–14. (PMID: 10.1155/2011/783976)
Yamada K, Mizukoshi E, Sunagozaka H, Arai K, Yamashita T, Takeshita Y, et al. Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis. Liver Int 2015;35:582–590. (PMID: 10.1111/liv.12685)
Hartmann P, Seebauer CT, Mazagova M, Horvath A, Wang L, Llorente C, et al. Deficiency of intestinal mucin-2 protects mice from diet-induced fatty liver disease and obesity. Am J Physiol Gastr Liver 2016;310:G310–G322. (PMID: 10.1152/ajpgi.00094.2015)
Puig J, Blasco G, Daunis-I-Estadella J, Loshuertos E, Codina J, Cuba V, et al. Nonalcoholic fatty liver disease and age are strong indicators for atherosclerosis in morbid obesity. Clin Endocrinol 2015;83:180–186. (PMID: 10.1111/cen.12698)
Li S, Tan HY, Wang N, Hong M, Li L, Cheung F, et al. Substitutes for bear bile for the treatment of liver diseases: research progress and future perspective. Evid Based Complement Alternat Med 2016;2016:4305074. (PMID: 270878224819118)
Lin LC, Yu KH, Wan TC, Cheng FU, Sakata R. Assessment of antioxidative capacity of animal bile and liver extracts. J Meat Product Meat Proc 2007;2:104–107.
Wan TC, Cheng FY, Lai KM, Liu YT, Lin LC. Study of in vitro cultured Calculus bovis on antioxidative capacity. J Chin Soc Anim Sci (Chin) 2008;37:55–65.
Li GG, Liang XF, Xie QL, Li GZ, Yu Y, Lai K. Gene structure, recombinant expression and functional characterization of grass carp leptin. Gen Comp Endocrinol 2010;166:117–27. (PMID: 10.1016/j.ygcen.2009.10.009)
Cui YC, Shan LQ, Liu XF, Shan GS, Gao H. Investigation of protective effect of different bile and their arisaema cum bile on acute lung injury rats induced by LPS. Chin J Exper Tra Med Form (Chin) 2020;26:125–132.
Lee G, Lee H, Hong J, Lee SH, Jung BH. Quantitative profiling of bile acids in rat bile using ultrahigh-performance liquid chromatography-orbitrap mass spectrometry: Alteration of the bile acid composition with aging. J Chromatogr B 2016;1031:37–49. (PMID: 10.1016/j.jchromb.2016.07.017)
Singh N, Bhattacharyya D. Identification of the anti-oxidant components in a two-step solvent extract of bovine bile lipid: application of reverse phase HPLC, mass spectrometry and fluorimetric assays. J Chromatogr B 2016;1019:83–94. (PMID: 10.1016/j.jchromb.2015.11.020)
Wang LY, Gao X, Tong ZL, Wang XG. Summary on pharmacological action and clinical study of the chemical composition of bear bile. Inf Tradit Chin Med (Chin) 2005;22:30–33.
Nagahashi M, Yuza K, Hirose Y, Nakajima M, Ramanathan R, Hait N, et al. The roles of bile acids and sphingosine-1-phosphate signaling in the hepatobiliary diseases. J Lipid Res 2016;57:1636–1643. (PMID: 10.1194/jlr.R069286)
Wu JS, Fang S, Li WK, Li YF, Li YY, Wang TM, et al. Metabolomics research on the hepatoprotective effect of cultured bear bile powder in α-naphthylisothiocyanate-induced cholestatic mice. J Chromatogr B Analyt Technol Biomed Life Sci 2020;1153:122269. (PMID: 10.1016/j.jchromb.2020.122269)
Wan TC, Liu YT, Duann LT, Yu KH, Chen CM, Lin LC, et al. Effects of animal liver and bile extracts on biochemical values of rat ethanol-induced fatty liver. Anim Sci J 2014;85:75–80. (PMID: 10.1111/asj.12088)
Zheng M, Li YY, Wang GF, Jin JY, Wang YH, Wang TM, et al. Protective effect of cultured bear bile powder against dimethylnitrosamine-induced hepatic fibrosis in rats. Biomed Pharmacother 2019;112:108701. (PMID: 10.1016/j.biopha.2019.108701)
Chen HW, Shen AL, Liu LY, Peng J, Chu JF. Bear bile powder inhibits growth of hepatocellular carcinoma via suppressing STAT3 signaling pathway in mice. Chin J Integr Med 2020;26:370–374. (PMID: 10.1007/s11655-019-3010-1)
Contributed Indexing:
Keywords: active ingredient; bile powders; lipid metabolism; liver
Substance Nomenclature:
0 (Biomarkers)
0 (Lipids)
0 (Powders)
516-50-7 (Taurodeoxycholic Acid)
724L30Y2QR (Ursodeoxycholic Acid)
Entry Date(s):
Date Created: 20210220 Date Completed: 20221003 Latest Revision: 20221003
Update Code:
20240105
DOI:
10.1007/s11655-021-3441-3
PMID:
33609233
Czasopismo naukowe
Objective: To compare the therapeutic effect of different animal bile powders on lipid metabolism disorders induced by high-fat diet in rats, and analyze the bioactive components of each animal bile powder.
Methods: Sixty Sprague-Dawley rats were randomly divided into 6 groups (n=10): normal diet control group, high-fat diet model group, high-fat diet groups orally treated with bear, pig, cow and chicken bile powders, respectively. Serum biochemical markers from the abdominal aorta in each group were analyzed. Changes in the body weight and liver weight were recorded. Pathohistological changes in the livers were examined. High performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry was used to determine the composition of bioactive components in each animal bile powder.
Results: Treatment with different types of animal bile powders had different inhibitory effects on high-fat diet-induced increase of body weight and/or liver weight in rats, most notably in bear and pig bile powders (P<0.05). High-fat diet induced lipid metabolism disorder in rats, which could be reversed by treatment with all kinds of bile powders. Bear bile and chicken bile showed the most potent therapeutic effect against lipid metabolism disorder. Cow and bear bile effectively alleviated high-fat diet induced liver enlargement and discoloration, hepatocyte swelling, infiltration of inflammatory cells and formation of lipid vacuoles. Bioactive component analysis revealed that there were significant differences in the relative content of taurocholic acid, taurodeoxycholic acid and ursodeoxycholic acid among different types of animal bile. Interestingly, a unique component with molecular weight of 496.2738 Da, whose function has not yet been reported, was identified only in bear bile powder.
Conclusions: Different animal bile powders had varying therapeutic effect against lipid metabolism disorders induced by high-fat diet, and bear bile powder demonstrated the most effective benefits. Bioactive compositions were different in different types of animal bile with a novel compound identified only in bear bile powder.
(© 2021. The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies